Real-time enrollment status for this plasma cell dyscrasias clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:08 PM UTC
| NCT Number | NCT01408225 |
| Recruiting Status | Recruiting |
| Condition | Plasma Cell Dyscrasias |
| Phase | Clinical Trial |
| Target Enrollment | 5,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | March 23, 2026 (Mar 23, 2026) |
As of July 13, 2026: Clinical trial NCT01408225 is currently recruiting participants. This clinical trial study for plasma cell dyscrasias is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01408225 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01408225 was last updated Mar 23, 2026 (March 23, 2026). HelloStudys verifies this status automatically.